Consonance Capital Management LP Bellus Health Inc. Put Options Transaction History
Consonance Capital Management LP
- $7.28 Million
- Q3 2022
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding BLU
# of Institutions
1Shares Held
128KCall Options Held
0Put Options Held
0About BELLUS Health Inc.
- Ticker BLU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 125,793,000
- Description
- BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...